Advances in MET tyrosine kinase inhibitors in gastric cancer
Gastric cancer is among the most frequently occurring cancers and a leading cause of cancer-related deaths globally. Because gastric cancer is highly heterogenous and comprised of different subtypes with distinct molecular and clinical characteristics, the management of gastric cancer calls for bett...
Shranjeno v:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
China Anti-Cancer Association
2024-06-01
|
| Serija: | Cancer Biology & Medicine |
| Teme: | |
| Online dostop: | https://www.cancerbiomed.org/content/21/6/484 |
| Oznake: |
Brez oznak, prvi označite!
|